Vanguard Group’s Urovant Sciences Ltd. UROV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-341,426
| Closed | -$5.51M | – | 4344 |
|
|
2020
Q4 | $5.51M | Buy |
341,426
+209,939
| +160% | +$3.39M | ﹤0.01% | 3320 |
|
|
2020
Q3 | $1.23M | Hold |
131,487
| – | – | ﹤0.01% | 3610 |
|
|
2020
Q2 | $1.29M | Hold |
131,487
| – | – | ﹤0.01% | 3546 |
|
|
2020
Q1 | $1.21M | Hold |
131,487
| – | – | ﹤0.01% | 3441 |
|
|
2019
Q4 | $2.04M | Hold |
131,487
| – | – | ﹤0.01% | 3442 |
|
|
2019
Q3 | $1.25M | Hold |
131,487
| – | – | ﹤0.01% | 3589 |
|
|
2019
Q2 | $1.04M | Buy |
131,487
+9,000
| +7% | +$71.2K | ﹤0.01% | 3666 |
|
|
2019
Q1 | $1.23M | Buy |
122,487
+30,163
| +33% | +$303K | ﹤0.01% | 3572 |
|
|
2018
Q4 | $608K | Buy |
+92,324
| New | +$608K | ﹤0.01% | 3687 |
|